We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Exercising Limbs May Help Parkinson's Patients

By Biotechdaily staff writers
Posted on 06 Jan 2005
In an animal model of Parkinson's disease, exercise was found to prevent degeneration of nerve cells that are normally impaired or destroyed by the disease. More...
Based on this finding, a small pilot study has been initiated in patients with the disease to determine if regular exercise can affect progression of the disease.

In Parkinson's disease, cells in the brain that contain dopamine, a neurotransmitter essential for purposeful and facile muscle control, progressively die until only a small percentage remains. Dopamine carries signals from the nerve cells, or neurons, located deep inside the brain in the substantia nigra along nerve fibers that end in the brain's striatum, an area involved in control of movement. In the absence of dopamine, neurons cannot send the appropriate messages for smooth motor control, resulting in the telltale symptoms of Parkinson's: uncontrollable tremors, rigidity of limbs, slow movements, and stooped posture.

Researchers examined the brains of rats that had been forced to exercise for seven days before receiving a toxin that normally induces Parkinson's. They found that, compared to animals that did not exercise, significantly fewer dopamine-containing neurons died. Proteins called neurotrophic factors protect neurons and promote their survival. One in particular, called GDNF, is increased with exercise by 40%.

"GDNF, and probably other factors as well, may help offset the cell's vulnerability to the effects of oxidative stress from free radical molecules that are produced by the toxin we use in our rat model,” explained Michael J. Zigmond, Ph.D., professor of neurology, neurobiology, and psychiatry at the University of Pittsburgh School of Medicine (PA, USA). Dr. Zigmond and colleagues are beginning a study whereby 20 patients with Parkinson's disease are enrolled in a 60-minute exercise program that meets three times a week.

"Our data suggest the possibility that exercise can make dopamine neurons resistant to neurotoxins and may therefore be a useful therapy for Parkinson's disease,” noted Annie D. Cohen, a doctoral student at the Pitt School of Medicine.





Related Links:
U. Pittsburgh Medical School

New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
New
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.